Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος των κανναβινοειδών στην αντιμετώπιση του οξέος πόνου: πειραματική μελέτη σε επίμυες
Abstract
dc:descriptionThe endogenous cannabinoid system is the subject of many scientific research groups worldwide. The purpose of our study was to establish the role of synthetic cannabinoids to the treatment of postoperative pain. There are indications that the peripheral CB2 cannabinoid receptors are best target for pain treatment, as well avoiding side effects of the central nervous system resulting from the activation of CB1 cannabinoid receptor. In the present study, we administered a selective agonist of the CB2 receptors, which was (R,S)-ΑΜ1241. Furthermore, we studied the antinociceptive effect of multimodal analgesia by administering cannabinoid and tramadol and the effectiveness of preemptive administration by administering analgesics before plantar incision. Pharmacological specificity was established by coadministration of agonists with antagonists.Pain and the immune system influence each other, making it difficult to determine whether blocking nociception contribute for a reduction in the production of proinflammatory cytokines or vice-versa, with the reduction in the formation of proinflammatory cytokines resulting in less severe pain. We elucidate the effect of cannabinoid and tramadol on immune system by determining the levels of two cytokines, IL-6 and IL-2.Forty-five adult male Wistar rats (250–300g) were used in this experimental setting. After reaching general anesthesia, a model of postsurgical pain in rats, similar to that previously described by Brennan, was applied with minor modifications. The analgesic drugs tested in our experiment study protocol were the CB2 agonist (R,S)-AM1241 (1mg/kg, i.p.) and tramadol (10mg/kg, i.p.). Time of administration was 30 minutes prior (preoperative) or immediately after surgery (postoperative). The two analgesics were administered alone but also in combination. Moreover, they were administered in combination with their antagonists, CB2 receptor antagonist SR144528 and naloxone, which is an antagonist of opioid. Thermal hyperalgesia assessment was performed with ¨ Hot plate Analgesia meter¨. Antinociceptive testing was performed 1h (baseline) before starting the experiment and at 30, 60 and 120 minutes after surgical incision. At the end of the experiment, blood samples were collected 2 hours after surgical incision, by receiving blood directly from the heart and used for determination of interleukins IL-6 and IL-2 by commercially available sandwich enzyme-linked immunosorbent assay (ELISA).The record and computation of the results gave the following conclusions:•(R,S)-AM1241 caused significant analgesia, which is not affected by time of administration and does not show significantly better analgesia than tramadol•SR144528, an antagonist of CB2 receptor, completely reverses the analgesia of (R,S)-AM1241 administration •preoperative administration of cannabinoid (R,S)-AM1241 causes a significant reduction of IL-6 •(R,S)-AM1241 does not affect significantly concentration of IL-2•tramadol induced significant analgesia, which is not affected by time of administration•antiallodynic effect produced by tramadol was partially reversed by naloxone•preoperative administration of tramadol causes a significant reduction of IL-6, •tramadol does not affect significantly concentration of IL-2•co-administration of (R,S)-AM1241 with tramadol causes significant relief of postoperative pain, has significantly better analgesic effect compared with cannabinoid and has not significantly better analgesic effect compared with tramadol•co-administration of (R,S)-AM1241 with tramadol causes significant reduction of IL-6•co-administration of (R,S)-AM1241 with tramadol does not affect significantly concentration of IL-2It therefore appears that, the size of postoperative analgesia of cannabinoid (R,S)-AM1241 is not impressive, not more than the widely administered tramadol. Tramadol, therefore, remains a good choice for postoperative analgesia, while more studies are needed to evaluate the action of cannabinoids and their use in treatment of acute pain.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stachtari, Chrysoula
- Στάχταρη, Χρυσούλα
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35667